✦ LIBER ✦

PDB87 STANDARDS FOR THE ASSESSMENT OF ANTIDIABETIC DRUGS—THE IQWIG PERSPECTIVE

✍ Scribed by B Schweikert; J John; A Ringborg; W Erhardt; A Bleckmann; AS Neubauer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for the cost-effective use of

✍ Peter Burrill; Andrew Krentz 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 83 KB

The utility of the zebrafish for drug sa

✍ Winter, Matthew J.; Ball, Jonathon; Goonesinghe, Alex; Hetheridge, Malcolm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Inconsistent trial assessments by the Na

✍ J. Hasford; P. Bramlage; G. Koch; W. Lehmacher; K. Einhäupl; P.M. Rothwell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Setting Standards for the Assessment of

✍ J.D. Beard 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Cardiovascular drugs as antidiabetic age

✍ D. P. Macfarlane; K. R. Paterson; M. Fisher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Regulatory perspective on the importance

✍ Banu S. Zolnik; Nakissa Sadrieh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 284 KB